NeuBase Therapeutics Inc (NBSE)
0.405
-0.01
(-1.72%)
USD |
NASDAQ |
May 03, 16:00
0.376
-0.03
(-7.16%)
After-Hours: 20:00
NeuBase Therapeutics Total Liabilities (Quarterly): 9.485M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 9.485M |
| June 30, 2023 | 11.09M |
| March 31, 2023 | 7.011M |
| December 31, 2022 | 7.359M |
| September 30, 2022 | 9.502M |
| June 30, 2022 | 9.684M |
| March 31, 2022 | 10.64M |
| December 31, 2021 | 9.910M |
| September 30, 2021 | 10.10M |
| June 30, 2021 | 9.043M |
| March 31, 2021 | 3.536M |
| December 31, 2020 | 2.242M |
| September 30, 2020 | 3.150M |
| June 30, 2020 | 3.472M |
| March 31, 2020 | 3.727M |
| December 31, 2019 | 2.849M |
| September 30, 2019 | 2.502M |
| June 30, 2019 | 0.7517M |
| March 31, 2019 | 0.6247M |
| December 31, 2018 | 0.5972M |
| September 30, 2018 | 0.2915M |
| June 30, 2018 | 0.8884M |
| March 31, 2018 | 1.732M |
| December 31, 2017 | 3.748M |
| September 30, 2017 | 5.084M |
| Date | Value |
|---|---|
| June 30, 2017 | 5.745M |
| March 31, 2017 | 7.042M |
| December 31, 2016 | 3.886M |
| September 30, 2016 | 4.482M |
| June 30, 2016 | 5.294M |
| March 31, 2016 | 3.516M |
| December 31, 2015 | 5.277M |
| September 30, 2015 | 3.88M |
| June 30, 2015 | 3.751M |
| March 31, 2015 | 3.284M |
| December 31, 2014 | 6.777M |
| September 30, 2014 | 5.273M |
| June 30, 2014 | 6.766M |
| March 31, 2014 | 0.9149M |
| December 31, 2013 | 0.2502M |
| September 30, 2013 | 0.4797M |
| June 30, 2013 | 0.2541M |
| March 31, 2013 | 0.3179M |
| December 31, 2012 | 2.384M |
| September 30, 2012 | 1.091M |
| June 30, 2012 | 2.420M |
| March 31, 2012 | 2.621M |
| December 31, 2011 | 5.525M |
| September 30, 2011 | 6.195M |
| June 30, 2011 | 5.187M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.7517M
Minimum
Jun 2019
11.09M
Maximum
Jun 2023
6.447M
Average
7.185M
Median
Total Liabilities (Quarterly) Benchmarks
| Ampio Pharmaceuticals Inc | 2.376M |
| Stoke Therapeutics Inc | 68.78M |
| ABVC BioPharma Inc | 6.362M |
| MAIA Biotechnology Inc | 7.089M |
| Aprea Therapeutics Inc | 5.697M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 18.62M |
| Shareholders Equity (Quarterly) | 9.137M |